SlideShare a Scribd company logo
2
Most read
6
Most read
7
Most read
BY
VANA JAGAN MOHAN RAO M.S.Pharm, MED.CHEM
NIPER-KOLKATA
Asst.Professor, MIPER-KURNOOL
Email: jaganvana6@gmail.com
What is Impurity?
• Impurity is defined as the presence of one
substance in another substance in lower
concentration.
• A Pharmaceutical Impurity is the unwanted
chemical that remain with the APIs (active
pharmaceutical ingredients) or develop during
formulation or upon aging of both API and
formulation.
• These impurities may influence the efficacy and
safety of Pharmaceutical product.
Any material that affects the purity of Pharmaceutical
drugs (or) products
• Presence of impurities may slow produce toxic
effects on the body and may also lower down
the active strength of Pharmaceutical substance.
• These impurities includes small quantities of
Lead, Arsenic, Chloride, Sulphate, Iron, etc.
UNWANTED
UNDESIRABLE
EXCESS
HARMFUL
• Impurity can be Organic, Inorganic, Microbial,
Residual solvents, Dust, Moisture, etc.
• In a pharmaceutical substance, the nature of
impurity can be predicted by the source from
which it has been obtained.
• There are 2 types of impurities in medicines:
a) Impurities associated in with APIs
b) Impurities that form are created during
formulation and with aging or that are related
to the formulated forms.
Impurities commonly found in medicinal preparations
 Impurities which have toxic effects on body and bring about unpleasant reactions when
present beyond certain limits. e.g Lead and Arsenic salts.
 The impurities which are able to make substance incompatible with other substances.
 The impurities which if present beyond the limit, affect the storage property of the
pharmaceuticals.
 The impurities which are harmless, but if present beyond the limit, it will lower the
active strength of the medicinal compound. E.g Sodium salt in potassium salt.
 The impurities which may bring about technical difficulties in the use of the substance.
 Impurities such as taste, odour, colour or appearance which can be easily detected by the
senses and make the substance unhygienic and unaesthetic. E.g. Sodium chloride becomes
damp because of the presence of traces of magnesium salts. Also phenolic impurities
present in sodium salicylate alters its odour.
Impurities imparted in pharmaceutical products
through:
• Raw materials
• Intermediates
• Reagents
• Catalysts & Solvents
• Reaction vessels
• Improper storage
• Cross contamination
• Manufacturing Errors
• Packing errors
• Microbial contamination
• Chemical instability
• Storage containers
• Atmospheric contamination
• Deliberate adulteration, etc.
RAW MATERIALS EMPLOYED IN MANUFACTURING
 Rock salt- CaSO4 + MgCl2 + NaCl
Calcium sulphate Magnesium Chloride Sodium Chloride
• Rock salt contains small amounts of Calcium sulphate and
Magnesium chloride. Thus Sodium chloride prepared from this
source will contain traces of Calcium and Magnesium compounds.
 Copper sulphate may be prepared by the action of sulphuric acid
on copper turnings:
• Cu+ 2 H2SO4 CuSO4 + 2 H2O + SO2
Copper turnings are known to have Iron and Arsenic as impurities.
INTERMEDIATES FORMED DURING MANUFACTURING
• Sometimes the Intermediates that are formed during the manufacturing may
be carried through to the final product as the impurity.
 Example:
• Potassium iodide is prepared by reacting Iodine with Potassium
hydroxide. 6KOH+ 3I2-------------------- 5KI + KIO3 + 3H2O
• The resulting solution is first evaporated and then heated with charcoal.
KIO3 + 3C ---------------------KI + 3CO
 In this process if the intermediate product (KIO3) is not completely converted
into KI, then it may be carried through to the final product as an impurity.
REAGENTS USED IN MANUFACTURING
• In manufacturing all the reagents will not be removed by the washing
process. So, some reagents may enter into the final products.
Example:
• Ammoniated mercury may be prepared by adding a solution of Mercuric
chloride to dilute ammonia solution.
• The precipitate of Ammoniated mercury (Final Product)contains
ammonium hydroxide.
• Thus, this precipitate is washed with cold water to remove ammonium
hydroxide.
• If it is not removed completely by washing with water, the final product
may contain in it.
• Ammonium hydroxide as impurity.
HgCl2+ 2NH4OH-------------NH2HgCl + NH4Cl + 2 H2O
Soluble soluble Ammoniated mercury (ppt) (soluble)
CATALYSTS
• If the used catalysts are not seperated from
the solution after the reaction it may be
observed in the final product.
Ex:- Enzymes
SOLVENTS USED IN MANUFACTURING
• Generally
water is
used as
solvent. It
may
containers
impurities.
Tap Water It has Ca+2, Mg+2, Na+, Cl-, SO -2 and CO -2 as
4 3
impurities in small amounts
Softened water It is obtained by allowing the tap water to pass
through the sodium form of Zeolite which
removes divalent cations like Ca+2 and Mg+2
from tap water in exchange of sodium.
So, softened water contains Na+, Cl- ions as
impurity.
De-mineralised
water
It is obtained by passing tap water through
columns packed with ion exchange resin.The
water obtained from this process is free from
Ca+2, Mg+2, Na+, Cl-, SO -2 and CO -2
4 3
Thus the final product is free from these
impurities.
The water obtained from this source may still
contain organic impurities and so final product
contains organic impurities.
Distilled water It is considered the best but it is very costly.
Esha Shah
REACTION VESSELS USED IN MANUFACTURING
• During manufacturing process, some of the solvents
and reagent may undergo reaction with metals of
reaction vessel and may dissolve these metals, which
appear as impurities in the final product.
Example:
 Iron is known to contain Arsenic impurity.
 The inorganic compounds manufactured in Iron vessel will contain
Arsenic and Iron as impurities.
 Thus IP has prescribed limit test for Arsenic and Iron for most
inorganic compounds.
IMPROPER STORAGE
 The chemical substances when prepared have to be stored in
different types of containers depending upon:
 Nature of the material
 Batch size
 Quantity
 Many types of materials are used for storage purpose like plastic,
polythene, iron vessels, stainless steel and aluminium.
Leaching out effect: Alkalies stored in ordinary glass containers
extract lead from it, which in found as impurity in the final product.
Strong chemicals react with iron containers and extract Iron an
impurity in final product.
• Inadequate storage and their effects are as
follows:
a) Filth: Stored products may become contaminated
with dust, bodies of insects, animal and insect
excreta.
b) Chemical instability: decomposition because
of light, traces of acid or alkali, air oxidation,
water vapour, CO2 and traces of metallic
ions.
• e.g. light sensitive materials should be stored in
amber colored bottles.
c) Reactions with container materials: e.g.
salicylic acid ointment must not be stored in
metal tubes.
d) Physical changes: The occurrence of changes in
the physical form of drug like change in crystal
size can lead to change in efficiency of product.
e) Temperature effect: Chemical and physical
changes occur if materials are not stored at proper
temperature.
CROSS CONTAMINATION
The handling of powders, granules, and tablets in
large bulk creates air-borne dust, which leads to
cross contamination of the product.
So, face masks and special extraction equipment
are used to protect operators from harmful effects
of drugs.
E.g penicillin preparation requires special handling
during its manufacture.
MANUFACTURING ERRORS
• In many manufacturing processes, there are defects like
imperfect mixing, incompleteness, non-adherence to proper
temperature, pressure, pH or reaction conditions, which may
give chemical compounds with impurities in them.
Example:
• Zinc oxide may be prepared by heating metallic zinc to bright redness
in a current of air. The vapours of Zinc burn to form Zinc oxide
which is collected as a fine white powder.
• But if there is less heat or air or both, zinc metal is not
completely converted to zinc oxide.
• Thus the final product, Zinc oxide may still contain metallic zinc as
impurity.
• So, IP has prescribed a test for Zinc metal in zinc oxide.
PACKAGING ERRORS
• Products of similar appearance such as tablets
of same size, shape, colour packed in similar
containers can constitute a potential source of
danger.
• Improper labelling or destruction of stock of
unused labels also constitutes a major
packaging hazard.
MICROBIAL CONTAMINATION
• Parenteral preparations and ophthalmic
preparations require special care against
microbial contamination.
• Many liquid preparations and creams are liable
to bacterial and fungal contamination. So care
should be taken.
• E.g., Acacia, senna, tragacanth---They
should be controlled for Salmonellae.
CHEMICAL INSTABILITY
For the synthesis of drugs, many chemical
reactions such as Nitration, Halogenation,
Oxidation, reduction, hydrolysis are involved.
In these chemical processes, different chemicals
are used. Those may observed as impurities.
Tap water is generally used in the various
processes and it is often having Cl-,Mg+2, Ca+2
ions, which are generally found in the substance
which is being manufactured.
STORAGE CONTAINERS
• If the storage containers are metals those are
highly reactive in nature with so many
chemical substances.
• It may lead to form some impurities after
manufacturing while storage.
ATMOSPHERIC CONTAMINATION
 In the industrial areas, the atmosphere is contaminated with dust particles
and some gases like Hydrogen sulphide, Sulphur dioxide, and black
smoke.
 During the manufacture or purification of the pharmaceutical products,
these impurities enter the final products.
 There are many pharmaceutical products which when manufactured
are contaminated with atmospheric CO2 and water vapour.
E.g. NaOH absorbs atmospheric CO2.
2NaOH + CO2 -------------------------------- Na2CO3 + H2O
 Due to this reaction, NaOH should not be kept open for a longer time
during its manufacture.
 Therefore, IP has prescribed that Sodium hydroxide should not contain more
than 3% of sodium carbonate.
DELIBERATE ADULTERATION
It is possible to avoid accidental substitution
by storing the toxic substances together
separately or in a locked cupboard.
Many pharmaceutical chemicals are
adulterated with cheaper substances.
E.g. The expensive potassium may be
adulterated with sodium bromide.
Sources and types of impurities

More Related Content

PDF
Sources of impurities
PPTX
Skeletal system
PPTX
Impurities in pharmaceutical substances
PPTX
Limit test for heavy metals
PPTX
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
PPT
Diagnostic agents
PDF
Limit test
PPTX
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Sources of impurities
Skeletal system
Impurities in pharmaceutical substances
Limit test for heavy metals
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Diagnostic agents
Limit test
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)

What's hot (20)

PPTX
Gastrointestinal agents
PPTX
Non aqueous titrations
PPTX
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
PPTX
Non aqueous titration
PPTX
Classification of powders
PDF
Modified limit tests for chlorides and sulphates.
PPTX
limit test for lead
PPT
PDF
Gastrointestinal agents
PPTX
Pharmacopoeia
PDF
Dental Product Pharmaceutical Inorganic Chemistry B.Pharm
PPTX
monophasic liquid dosage forms
PPTX
Dental products
PPTX
Suspensions
PPTX
7.limit test for arsenic
PDF
Errors in Pharmaceutical analysis.pdf
PDF
History of pharmacopoeia 1
PPTX
Estimation of MgSO4 &calcium gluconate
PPTX
DENTAL PRODUCTS
PPTX
Posology and Factors affecting to posology
Gastrointestinal agents
Non aqueous titrations
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Non aqueous titration
Classification of powders
Modified limit tests for chlorides and sulphates.
limit test for lead
Gastrointestinal agents
Pharmacopoeia
Dental Product Pharmaceutical Inorganic Chemistry B.Pharm
monophasic liquid dosage forms
Dental products
Suspensions
7.limit test for arsenic
Errors in Pharmaceutical analysis.pdf
History of pharmacopoeia 1
Estimation of MgSO4 &calcium gluconate
DENTAL PRODUCTS
Posology and Factors affecting to posology
Ad

Similar to Sources and types of impurities (20)

PPTX
IMPURITIES.pptx
PPTX
ddshbfdjfbjhfbdhbdhsjfhjdfbdjbfdhsbsdj123.pptx
PPTX
Impurity (effect and sources)
PPTX
Pharmaceutical impurities
DOCX
PPTX
Impurites
PPTX
sources of impurities.pptx
PDF
IMPURITIES-IN-PCEUTICAL-SUB-PIC-SEM-I.pdf
PDF
Sources-of-Impurities-.pdf
PDF
Sources-of-Impurities-. PPT
PPTX
IMPURITIES
PPTX
sources of impurities andminimization of errors
PPTX
Impurities in pharmaceutical substances.pptx
PPTX
Impurities in Pharmaceuticals
DOCX
Quality control drugs and pharmaceuticals
PDF
Pharmaceutical impurity and limit test_by_Raju_Yadav_M.S._Pharm_NIPER_2020
PPTX
PPTX
PDF
Impurities and their limit test
IMPURITIES.pptx
ddshbfdjfbjhfbdhbdhsjfhjdfbdjbfdhsbsdj123.pptx
Impurity (effect and sources)
Pharmaceutical impurities
Impurites
sources of impurities.pptx
IMPURITIES-IN-PCEUTICAL-SUB-PIC-SEM-I.pdf
Sources-of-Impurities-.pdf
Sources-of-Impurities-. PPT
IMPURITIES
sources of impurities andminimization of errors
Impurities in pharmaceutical substances.pptx
Impurities in Pharmaceuticals
Quality control drugs and pharmaceuticals
Pharmaceutical impurity and limit test_by_Raju_Yadav_M.S._Pharm_NIPER_2020
Impurities and their limit test
Ad

More from jagan vana (20)

PPTX
Haemophilia
PPTX
Gonorrhoea
PPTX
Pathophysiology of Asthma
PPTX
corrosion
PPTX
11. materialsof construction
PPTX
centrifugation
PPTX
filtration
PPTX
mixing
PPTX
drying
PPTX
distillation
PPTX
evaporation
PPTX
heat transfer
PPTX
size seperation
PPTX
size reduction
PPTX
flow of fluids
PPTX
Transplantation and tissue rejection
PPTX
Organ function tests
PPTX
Neoplastic diseases
PPTX
Leprosy
PPTX
Inflammatory bowel diseases
Haemophilia
Gonorrhoea
Pathophysiology of Asthma
corrosion
11. materialsof construction
centrifugation
filtration
mixing
drying
distillation
evaporation
heat transfer
size seperation
size reduction
flow of fluids
Transplantation and tissue rejection
Organ function tests
Neoplastic diseases
Leprosy
Inflammatory bowel diseases

Recently uploaded (20)

PDF
102 student loan defaulters named and shamed – Is someone you know on the list?
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PDF
Module 4: Burden of Disease Tutorial Slides S2 2025
PPTX
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
PPTX
Cell Structure & Organelles in detailed.
PDF
Supply Chain Operations Speaking Notes -ICLT Program
PDF
Abdominal Access Techniques with Prof. Dr. R K Mishra
PPTX
Institutional Correction lecture only . . .
PDF
Microbial disease of the cardiovascular and lymphatic systems
PDF
Computing-Curriculum for Schools in Ghana
PDF
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
PDF
Anesthesia in Laparoscopic Surgery in India
PPTX
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
PDF
Insiders guide to clinical Medicine.pdf
PPTX
Pharma ospi slides which help in ospi learning
PPTX
human mycosis Human fungal infections are called human mycosis..pptx
PPTX
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
PDF
O5-L3 Freight Transport Ops (International) V1.pdf
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PPTX
master seminar digital applications in india
102 student loan defaulters named and shamed – Is someone you know on the list?
STATICS OF THE RIGID BODIES Hibbelers.pdf
Module 4: Burden of Disease Tutorial Slides S2 2025
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
Cell Structure & Organelles in detailed.
Supply Chain Operations Speaking Notes -ICLT Program
Abdominal Access Techniques with Prof. Dr. R K Mishra
Institutional Correction lecture only . . .
Microbial disease of the cardiovascular and lymphatic systems
Computing-Curriculum for Schools in Ghana
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
Anesthesia in Laparoscopic Surgery in India
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
Insiders guide to clinical Medicine.pdf
Pharma ospi slides which help in ospi learning
human mycosis Human fungal infections are called human mycosis..pptx
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
O5-L3 Freight Transport Ops (International) V1.pdf
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
master seminar digital applications in india

Sources and types of impurities

  • 1. BY VANA JAGAN MOHAN RAO M.S.Pharm, MED.CHEM NIPER-KOLKATA Asst.Professor, MIPER-KURNOOL Email: jaganvana6@gmail.com
  • 2. What is Impurity? • Impurity is defined as the presence of one substance in another substance in lower concentration. • A Pharmaceutical Impurity is the unwanted chemical that remain with the APIs (active pharmaceutical ingredients) or develop during formulation or upon aging of both API and formulation. • These impurities may influence the efficacy and safety of Pharmaceutical product.
  • 3. Any material that affects the purity of Pharmaceutical drugs (or) products • Presence of impurities may slow produce toxic effects on the body and may also lower down the active strength of Pharmaceutical substance. • These impurities includes small quantities of Lead, Arsenic, Chloride, Sulphate, Iron, etc. UNWANTED UNDESIRABLE EXCESS HARMFUL
  • 4. • Impurity can be Organic, Inorganic, Microbial, Residual solvents, Dust, Moisture, etc. • In a pharmaceutical substance, the nature of impurity can be predicted by the source from which it has been obtained. • There are 2 types of impurities in medicines: a) Impurities associated in with APIs b) Impurities that form are created during formulation and with aging or that are related to the formulated forms.
  • 5. Impurities commonly found in medicinal preparations  Impurities which have toxic effects on body and bring about unpleasant reactions when present beyond certain limits. e.g Lead and Arsenic salts.  The impurities which are able to make substance incompatible with other substances.  The impurities which if present beyond the limit, affect the storage property of the pharmaceuticals.  The impurities which are harmless, but if present beyond the limit, it will lower the active strength of the medicinal compound. E.g Sodium salt in potassium salt.  The impurities which may bring about technical difficulties in the use of the substance.  Impurities such as taste, odour, colour or appearance which can be easily detected by the senses and make the substance unhygienic and unaesthetic. E.g. Sodium chloride becomes damp because of the presence of traces of magnesium salts. Also phenolic impurities present in sodium salicylate alters its odour.
  • 6. Impurities imparted in pharmaceutical products through: • Raw materials • Intermediates • Reagents • Catalysts & Solvents • Reaction vessels • Improper storage • Cross contamination • Manufacturing Errors • Packing errors • Microbial contamination • Chemical instability • Storage containers • Atmospheric contamination • Deliberate adulteration, etc.
  • 7. RAW MATERIALS EMPLOYED IN MANUFACTURING  Rock salt- CaSO4 + MgCl2 + NaCl Calcium sulphate Magnesium Chloride Sodium Chloride • Rock salt contains small amounts of Calcium sulphate and Magnesium chloride. Thus Sodium chloride prepared from this source will contain traces of Calcium and Magnesium compounds.  Copper sulphate may be prepared by the action of sulphuric acid on copper turnings: • Cu+ 2 H2SO4 CuSO4 + 2 H2O + SO2 Copper turnings are known to have Iron and Arsenic as impurities.
  • 8. INTERMEDIATES FORMED DURING MANUFACTURING • Sometimes the Intermediates that are formed during the manufacturing may be carried through to the final product as the impurity.  Example: • Potassium iodide is prepared by reacting Iodine with Potassium hydroxide. 6KOH+ 3I2-------------------- 5KI + KIO3 + 3H2O • The resulting solution is first evaporated and then heated with charcoal. KIO3 + 3C ---------------------KI + 3CO  In this process if the intermediate product (KIO3) is not completely converted into KI, then it may be carried through to the final product as an impurity.
  • 9. REAGENTS USED IN MANUFACTURING • In manufacturing all the reagents will not be removed by the washing process. So, some reagents may enter into the final products. Example: • Ammoniated mercury may be prepared by adding a solution of Mercuric chloride to dilute ammonia solution. • The precipitate of Ammoniated mercury (Final Product)contains ammonium hydroxide. • Thus, this precipitate is washed with cold water to remove ammonium hydroxide. • If it is not removed completely by washing with water, the final product may contain in it. • Ammonium hydroxide as impurity. HgCl2+ 2NH4OH-------------NH2HgCl + NH4Cl + 2 H2O Soluble soluble Ammoniated mercury (ppt) (soluble)
  • 10. CATALYSTS • If the used catalysts are not seperated from the solution after the reaction it may be observed in the final product. Ex:- Enzymes
  • 11. SOLVENTS USED IN MANUFACTURING • Generally water is used as solvent. It may containers impurities. Tap Water It has Ca+2, Mg+2, Na+, Cl-, SO -2 and CO -2 as 4 3 impurities in small amounts Softened water It is obtained by allowing the tap water to pass through the sodium form of Zeolite which removes divalent cations like Ca+2 and Mg+2 from tap water in exchange of sodium. So, softened water contains Na+, Cl- ions as impurity. De-mineralised water It is obtained by passing tap water through columns packed with ion exchange resin.The water obtained from this process is free from Ca+2, Mg+2, Na+, Cl-, SO -2 and CO -2 4 3 Thus the final product is free from these impurities. The water obtained from this source may still contain organic impurities and so final product contains organic impurities. Distilled water It is considered the best but it is very costly. Esha Shah
  • 12. REACTION VESSELS USED IN MANUFACTURING • During manufacturing process, some of the solvents and reagent may undergo reaction with metals of reaction vessel and may dissolve these metals, which appear as impurities in the final product. Example:  Iron is known to contain Arsenic impurity.  The inorganic compounds manufactured in Iron vessel will contain Arsenic and Iron as impurities.  Thus IP has prescribed limit test for Arsenic and Iron for most inorganic compounds.
  • 13. IMPROPER STORAGE  The chemical substances when prepared have to be stored in different types of containers depending upon:  Nature of the material  Batch size  Quantity  Many types of materials are used for storage purpose like plastic, polythene, iron vessels, stainless steel and aluminium. Leaching out effect: Alkalies stored in ordinary glass containers extract lead from it, which in found as impurity in the final product. Strong chemicals react with iron containers and extract Iron an impurity in final product.
  • 14. • Inadequate storage and their effects are as follows: a) Filth: Stored products may become contaminated with dust, bodies of insects, animal and insect excreta. b) Chemical instability: decomposition because of light, traces of acid or alkali, air oxidation, water vapour, CO2 and traces of metallic ions. • e.g. light sensitive materials should be stored in amber colored bottles. c) Reactions with container materials: e.g. salicylic acid ointment must not be stored in metal tubes. d) Physical changes: The occurrence of changes in the physical form of drug like change in crystal size can lead to change in efficiency of product. e) Temperature effect: Chemical and physical changes occur if materials are not stored at proper temperature.
  • 15. CROSS CONTAMINATION The handling of powders, granules, and tablets in large bulk creates air-borne dust, which leads to cross contamination of the product. So, face masks and special extraction equipment are used to protect operators from harmful effects of drugs. E.g penicillin preparation requires special handling during its manufacture.
  • 16. MANUFACTURING ERRORS • In many manufacturing processes, there are defects like imperfect mixing, incompleteness, non-adherence to proper temperature, pressure, pH or reaction conditions, which may give chemical compounds with impurities in them. Example: • Zinc oxide may be prepared by heating metallic zinc to bright redness in a current of air. The vapours of Zinc burn to form Zinc oxide which is collected as a fine white powder. • But if there is less heat or air or both, zinc metal is not completely converted to zinc oxide. • Thus the final product, Zinc oxide may still contain metallic zinc as impurity. • So, IP has prescribed a test for Zinc metal in zinc oxide.
  • 17. PACKAGING ERRORS • Products of similar appearance such as tablets of same size, shape, colour packed in similar containers can constitute a potential source of danger. • Improper labelling or destruction of stock of unused labels also constitutes a major packaging hazard.
  • 18. MICROBIAL CONTAMINATION • Parenteral preparations and ophthalmic preparations require special care against microbial contamination. • Many liquid preparations and creams are liable to bacterial and fungal contamination. So care should be taken. • E.g., Acacia, senna, tragacanth---They should be controlled for Salmonellae.
  • 19. CHEMICAL INSTABILITY For the synthesis of drugs, many chemical reactions such as Nitration, Halogenation, Oxidation, reduction, hydrolysis are involved. In these chemical processes, different chemicals are used. Those may observed as impurities. Tap water is generally used in the various processes and it is often having Cl-,Mg+2, Ca+2 ions, which are generally found in the substance which is being manufactured.
  • 20. STORAGE CONTAINERS • If the storage containers are metals those are highly reactive in nature with so many chemical substances. • It may lead to form some impurities after manufacturing while storage.
  • 21. ATMOSPHERIC CONTAMINATION  In the industrial areas, the atmosphere is contaminated with dust particles and some gases like Hydrogen sulphide, Sulphur dioxide, and black smoke.  During the manufacture or purification of the pharmaceutical products, these impurities enter the final products.  There are many pharmaceutical products which when manufactured are contaminated with atmospheric CO2 and water vapour. E.g. NaOH absorbs atmospheric CO2. 2NaOH + CO2 -------------------------------- Na2CO3 + H2O  Due to this reaction, NaOH should not be kept open for a longer time during its manufacture.  Therefore, IP has prescribed that Sodium hydroxide should not contain more than 3% of sodium carbonate.
  • 22. DELIBERATE ADULTERATION It is possible to avoid accidental substitution by storing the toxic substances together separately or in a locked cupboard. Many pharmaceutical chemicals are adulterated with cheaper substances. E.g. The expensive potassium may be adulterated with sodium bromide.